Peer-reviewed evidence
Sophisticated plant extract inhibits in vitro the growth and biofilm formation of Staphylococcus pseudintermedius isolated from canine skin and ear infections
In vitro evaluation of WECMEP 16P576 against 43 clinical Staphylococcus pseudintermedius isolates from canine skin and ear infections. The extract inhibited growth in 40/43 strains at 0.5 g/L and achieved more than 90% biofilm inhibition (average), including against antibiotic-resistant isolates. Results were reproducible across plant-source variations, supporting further investigation as a topical approach for canine superficial pyoderma and otitis externa.
43canine isolates tested
40/43growth inhibition at 500µg/mL(43/43 at 0.2% w/v)
More than
90%biofilm inhibition (average)
Why this matters for veterinarians
Effective against antibiotic multiresistant clinical strains
Demonstrated activity against 43 clinical Staphylococcus pseudintermedius isolates from skin and ear infections.
Potent biofilm control
Achieved more than 90% biofilm inhibition (average), including against antibiotic-resistant isolates.
Plant-based innovation
Reproducible results across plant-source variations, supporting a novel topical approach.